Secondary Logo

Journal Logo

Articles by Lan Lin, MD

Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus–16/18 Vaccine in Four- to Six-year-old Girls: Three-year Follow-up of a Randomized Phase III Trial

Lin, Lan; Macias Parra, Mercedes; Sierra, Victor Y.; More

The Pediatric Infectious Disease Journal. 38(10):1061-1067, October 2019.

Safety and Immunogenicity of the HPV-16/18 AS04-adjuvanted Vaccine in 4–6-year-old Girls: Results to Month 12 From a Randomized Trial

Lin, Lan; Parra, Mercedes Macias; Sierra, Victor Y.; More

The Pediatric Infectious Disease Journal. 37(4):e93-e102, April 2018.

Long-term Immunogenicity and Safety of the HPV-16/18 AS04-adjuvanted Vaccine in 10- to 14-year-old Girls: Open 6-year Follow-up of an Initial Observer-blinded, Randomized Trial

Schwarz, Tino F.; Huang, Li-Min; Lin, Tzou-Yien; More

The Pediatric Infectious Disease Journal. 33(12):1255-1261, December 2014.